At Arcutis, this is our purpose and our passion.
With extensive medical dermatology development and commercial expertise, a drug development platform focused on established inflammatory pathways, as well as a deep understanding of what really matters to individuals and their healthcare providers, we work to address real-world, unmet needs through meaningful innovation.
For too long, medical dermatology has not been focused on the long-term disease management. We are changing that by delivering meaningful innovation that is meant to be used throughout the treatment journey for individuals living with chronic inflammatory skin diseases.


At Arcutis, we’re committed to understanding what matters most to individuals with chronic inflammatory skin conditions and their healthcare professionals. Watch the video to see how we’re bringing to life meaningful innovation that solves real-world problems.

Focusing on established scientific pathways, our dermatology drug development platform fuels a growing pipeline of novel immuno-dermatology therapies targeting multiple dermatologic indications.

With an understanding of the pain points that healthcare providers and individuals experience and a shared sense of urgency to address them — we’re uniquely equipped to solve the most persistent challenges in treating immune-driven dermatological diseases and conditions.

Founded in 2016 by a leadership team with extensive dermatology and commercialization experience — including 50+ FDA-approved products among them and multiple dermatology clinicians on staff.
The complexities of treating chronic inflammatory diseases of the skin. The need for more innovative treatments. The real, everyday needs of those living with immune-mediated skin conditions.
We want to know what matters most to you. Let us know what’s on your mind using the form.
This site is protected by reCAPTCHA and the Google
Privacy Policy and Terms of Service apply.
Download our corporate fact sheet.
Download